ZA200809917B - Crystalline forms of 4- [2-(4-Methylphenylsulfanyl) - Phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain - Google Patents

Crystalline forms of 4- [2-(4-Methylphenylsulfanyl) - Phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain

Info

Publication number
ZA200809917B
ZA200809917B ZA200809917A ZA200809917A ZA200809917B ZA 200809917 B ZA200809917 B ZA 200809917B ZA 200809917 A ZA200809917 A ZA 200809917A ZA 200809917 A ZA200809917 A ZA 200809917A ZA 200809917 B ZA200809917 B ZA 200809917B
Authority
ZA
South Africa
Prior art keywords
methylphenylsulfanyl
piperidine
phenyl
treatment
neuropathic pain
Prior art date
Application number
ZA200809917A
Inventor
Benny Bang-Andersen
Andre Faldt
Tine Bryan Stensboel
Silke Miller
De Diego Heidi Lopez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of ZA200809917B publication Critical patent/ZA200809917B/en

Links

ZA200809917A 2006-06-16 2007-06-15 Crystalline forms of 4- [2-(4-Methylphenylsulfanyl) - Phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain ZA200809917B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200600816 2006-06-16

Publications (1)

Publication Number Publication Date
ZA200809917B true ZA200809917B (en) 2010-08-25

Family

ID=40829512

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809917A ZA200809917B (en) 2006-06-16 2007-06-15 Crystalline forms of 4- [2-(4-Methylphenylsulfanyl) - Phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain

Country Status (4)

Country Link
CN (1) CN101472891B (en)
ES (1) ES2361949T3 (en)
UA (1) UA95801C2 (en)
ZA (1) ZA200809917B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104710345B (en) * 2013-12-17 2017-09-05 江苏恩华药业股份有限公司 For preparing 4（2‑（4 aminomethyl phenyl sulfenyls））Compound, its preparation method and the application of Phenylpiperidine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (en) * 2001-10-04 2008-02-11 Х. Луннбек А/С Derivated of phenylpiperazine as serotonin reuptake inhibitorS

Also Published As

Publication number Publication date
CN101472891A (en) 2009-07-01
UA95801C2 (en) 2011-09-12
ES2361949T3 (en) 2011-06-24
CN101472891B (en) 2013-08-21

Similar Documents

Publication Publication Date Title
HK1134287A1 (en) Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
IL197420A0 (en) Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-
HK1142007A1 (en) 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
IL192241A0 (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
IL195273A0 (en) Pharmaceutical use of substituted piperidine carboxamides
NO343929B3 (en) 1- [2- (2,4-dimethylphenylsulfanyl-phenyl] -piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5HT1A activity for the treatment of cognitive pain
SI1968949T1 (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
EP1983972A4 (en) Compounds for the treatment of metabolic disorders
IL195203A0 (en) Compounds for the treatment of metabolic disorders
IL212640A0 (en) Process for the preparation of piperazine compounds and hydrochloride salts thereof
NZ592543A (en) 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
IL192852A0 (en) Compounds for the treatment of metabolic disorders
EP2024323A4 (en) Salts of trimebutine and n-desmethyl trimebutine
GB0612506D0 (en) Crystalline duloxetine hydrochloride
EP2114150A4 (en) Combinations of dopamine d2 receptor blockade with norepinephrine reuptake inhibition and with norepinephrine alpha 2 receptor blockade
PT2044020E (en) Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
HK1140949A1 (en) Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl) phenyl]piperidine 4-[2-(4-)-]
ZA200809917B (en) Crystalline forms of 4- [2-(4-Methylphenylsulfanyl) - Phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
IL192851A0 (en) Compounds for the treatment of metabolic disorders
IL195392A0 (en) Compounds for the treatment of metabolic disorders
HK1112612A1 (en) 3-(2-(dimethylamino)methyl(cyclohex-1-yl))phenol maleate and its crystalline forms
IL198999A0 (en) Compounds with a combination of cannabinobi-cb1 antagonism and serotonin reuptake inhibition
EP2285365A4 (en) Use of a composition comprising at least one beta-blocker for the treatment of sleep disorders
IL192982A0 (en) Compounds for the treatment of metabolic disorders